Cardiac regeneration using pluripotent stem cells—Progression to large animal models
Open Access
- 1 November 2014
- journal article
- review article
- Published by Elsevier in Stem Cell Research
- Vol. 13 (3) , 654-665
Abstract
No abstract availableKeywords
Funding Information
- NIH (P01HL094374, R01HL084642, U01HL100405, P01GM08619)
- Institute of Translational Health Sciences/Primate Center Ignition Award
This publication has 82 references indexed in Scilit:
- Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured heartsNature, 2012
- Direct Comparison of Different Stem Cell Types and Subpopulations Reveals Superior Paracrine Potency and Myocardial Repair Efficacy With Cardiosphere-Derived CellsJACC, 2012
- Production of De Novo Cardiomyocytes: Human Pluripotent Stem Cell Differentiation and Direct ReprogrammingCell Stem Cell, 2012
- RETRACTED: Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trialThe Lancet, 2011
- Paracrine mechanisms of stem cell reparative and regenerative actions in the heartJournal of Molecular and Cellular Cardiology, 2011
- Human embryonic stem cell-derived cardiomyocytes engraft but do not alter cardiac remodeling after chronic infarction in ratsJournal of Molecular and Cellular Cardiology, 2010
- A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study of Intravenous Adult Human Mesenchymal Stem Cells (Prochymal) After Acute Myocardial InfarctionJACC, 2009
- Systems approaches to preventing transplanted cell death in cardiac repairJournal of Molecular and Cellular Cardiology, 2008
- Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repairProceedings of the National Academy of Sciences, 2007
- Differences between human and mouse embryonic stem cellsDevelopmental Biology, 2004